Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

715
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
715
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

4.1K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.1K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

4.7K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.7K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

1.9K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
1.9K
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

452
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
452
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

404
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
404

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

HFpEF risk assessment using H<sub>2</sub>FPEF score in community-dwelling young Hispanic adults.

Frontiers in cardiovascular medicine·2026
Same author

Associations Between Metabolic Dysregulation and Stage B Heart Failure in Hispanic Populations.

Echocardiography (Mount Kisco, N.Y.)·2026
Same author

Integrated Genomic and Transcriptomic Study Reveals <i>MAPK11</i> and <i>PER1</i> as Important Obesity Susceptibility Genes in a High-Risk Hispanic/Latino Population.

Circulation. Genomic and precision medicine·2026
Same author

Local ancestry modulates gene expression: shifting our understanding of genetic regulation and disease association within and across populations.

medRxiv : the preprint server for health sciences·2026
Same author

Gene-by-Sleep Duration Interaction for Glycemic Traits in over 480,000 Individuals.

medRxiv : the preprint server for health sciences·2026
Same author

Genome-wide gene-sleep interaction study identifies novel lipid loci in 732,564 participants.

Atherosclerosis·2025

Related Experiment Video

Updated: Dec 14, 2025

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

19.1K

Worldwide increase in diabetes: implications for tuberculosis control.

Susan P Fisher-Hoch1

  • 1Division of Epidemiology, Human Genetics and Environmental Science, University of Texas School of Public Health, Brownsville Campus, Brownsville, TX, USA.

Research and Reports in Tropical Medicine
|July 17, 2020
PubMed
Summary
This summary is machine-generated.

Diabetes significantly threatens global tuberculosis (TB) control, increasing drug resistance and mortality. Improved screening and tailored treatments are crucial for managing both diabetes and TB effectively.

Keywords:
MDR-TBglobal public healthtype 2 diabetes

More Related Videos

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

3.1K
Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT
08:13

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT

Published on: January 7, 2018

70.9K

Related Experiment Videos

Last Updated: Dec 14, 2025

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

19.1K
A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

3.1K
Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT
08:13

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT

Published on: January 7, 2018

70.9K

Area of Science:

  • Global Health
  • Infectious Diseases
  • Endocrinology

Background:

  • Diabetes affects 382 million globally, with many undiagnosed, disproportionately in low- and middle-income countries where tuberculosis (TB) is also prevalent.
  • Type 2 diabetes shows a recent tripling in TB cases, particularly in high-burden TB regions, posing a greater long-term threat than HIV/AIDS.
  • Diabetes exacerbates TB by increasing drug resistance, treatment failure, mortality, and potentially the spread of resistant strains.

Purpose of the Study:

  • To highlight the significant and growing threat of diabetes to global tuberculosis control efforts.
  • To emphasize the need for improved screening strategies and tailored treatment approaches for individuals with both conditions.
  • To advocate for research into new diagnostics, cost-effective interventions, and understanding immune responses in diabetes patients susceptible to TB.

Main Methods:

  • Review of current global diabetes and TB prevalence data.
  • Analysis of the impact of diabetes on TB outcomes, including drug resistance and mortality.
  • Assessment of existing World Health Organization (WHO) frameworks and identification of gaps in screening and care.

Main Results:

  • Diabetes is a major, underestimated threat to TB control, potentially reversing decades of progress.
  • Diabetes increases TB complexity, leading to higher rates of drug resistance, treatment failure, and death.
  • Current screening strategies and diagnostic tools for bi-directional TB-diabetes care are inadequate.

Conclusions:

  • Urgent, integrated strategies are needed to address the dual burden of diabetes and TB.
  • Enhanced screening, tailored treatment protocols, and robust research are essential for effective control.
  • Political will, funding, and scientific advancements are critical to overcome this global health challenge.